These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 1280744

  • 1. Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.
    Anderson FL, Port JD, Reid BB, Hanson G, Kralios AC, Hershberger RE, Bristow MR.
    J Cardiovasc Pharmacol; 1992; 20(5):800-6. PubMed ID: 1280744
    [Abstract] [Full Text] [Related]

  • 2. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
    Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV.
    J Clin Invest; 1992 Mar; 89(3):803-15. PubMed ID: 1311717
    [Abstract] [Full Text] [Related]

  • 3. Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation.
    Anderson FL, Port JD, Reid BB, Larrabee P, Hanson G, Bristow MR.
    Circulation; 1992 Jan; 85(1):46-53. PubMed ID: 1309447
    [Abstract] [Full Text] [Related]

  • 4. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 5. [Myocardial catecholamine content in heart failure--I: Regional distribution in explanted hearts. Comparison between dilated cardiomyopathy and coronary heart disease].
    Regitz V, Sasse S, Bossaller C, Strasser R, Schüler S, Hetzer R, Fleck E.
    Z Kardiol; 1989 Dec; 78(12):751-8. PubMed ID: 2623916
    [Abstract] [Full Text] [Related]

  • 6. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
    Lee HR, Hershberger RE, Port JD, Rasmussen R, Renlund DG, O'Connell JB, Gilbert EM, Mealey PC, Volkman K, Menlove R.
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
    [Abstract] [Full Text] [Related]

  • 7. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
    Port JD, Gilbert EM, Larrabee P, Mealey P, Volkman K, Ginsburg R, Hershberger RE, Murray J, Bristow MR.
    Circulation; 1990 Mar; 81(3):929-38. PubMed ID: 1968367
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Baumann G, Ningel K, Permanetter B.
    J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
    [Abstract] [Full Text] [Related]

  • 9. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.
    Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J.
    Circulation; 1991 Sep; 84(3):1024-39. PubMed ID: 1653120
    [Abstract] [Full Text] [Related]

  • 10. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
    Goldberg LI, Kohli JD, Cantacuzene D, Kirk KL, Creveling CR.
    J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
    [Abstract] [Full Text] [Related]

  • 11. Consequences of coronary occlusion on changes in regional interstitial myocardial neuropeptide Y and norepinephrine concentrations.
    Mertes PM, el-Abbassi K, Jaboin Y, Michel C, Beck B, Pinelli G, Carteaux JP, Villemot JP, Burlet C.
    J Mol Cell Cardiol; 1996 Sep; 28(9):1995-2004. PubMed ID: 8899558
    [Abstract] [Full Text] [Related]

  • 12. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts.
    Linck B, Bokník P, Eschenhagen T, Müller FU, Neumann J, Nose M, Jones LR, Schmitz W, Scholz H.
    Cardiovasc Res; 1996 Apr; 31(4):625-32. PubMed ID: 8689655
    [Abstract] [Full Text] [Related]

  • 13. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
    Dubois-Randé JL, Comoy E, Merlet P, Benvenuti C, Carville C, Hittinger L, Macquin-Mavier I, Bohuon C, Castaigne A.
    Eur Heart J; 1992 Sep; 13(9):1233-8. PubMed ID: 1396834
    [Abstract] [Full Text] [Related]

  • 14. [Myocardial catecholamine content in heart failure--II: Measurement in endomyocardial biopsies, reference systems, normal values].
    Regitz V, Sasse S, Fleck E.
    Z Kardiol; 1989 Dec; 78(12):759-63. PubMed ID: 2623917
    [Abstract] [Full Text] [Related]

  • 15. Calcium sparks in human ventricular cardiomyocytes from patients with terminal heart failure.
    Lindner M, Brandt MC, Sauer H, Hescheler J, Böhle T, Beuckelmann DJ.
    Cell Calcium; 2002 Apr; 31(4):175-82. PubMed ID: 12027382
    [Abstract] [Full Text] [Related]

  • 16. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP, Tweddel AC, Hutton I.
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.
    Goldberg LI.
    J Cardiovasc Pharmacol; 1989 Feb; 14 Suppl 8():S21-8. PubMed ID: 2483439
    [Abstract] [Full Text] [Related]

  • 18. Region specific regulation of sodium pump isoform and Na,Ca-exchanger expression in the failing human heart--right atrium vs left ventricle.
    Müller-Ehmsen J, Wang J, Schwinger RH, McDonough AA.
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):373-81. PubMed ID: 11357898
    [Abstract] [Full Text] [Related]

  • 19. Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy.
    Merlet P, Dubois-Randé JL, Adnot S, Bourguignon MH, Benvenuti C, Loisance D, Valette H, Castaigne A, Syrota A.
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):10-6. PubMed ID: 1375674
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneous transmural distribution of beta-adrenergic receptor subtypes in failing human hearts.
    Beau SL, Tolley TK, Saffitz JE.
    Circulation; 1993 Dec; 88(6):2501-9. PubMed ID: 7902783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.